Organ preservation in patients with squamous cancers of the head and neck

Surgical Oncology Clinics of North America

Volumn 13, Issue 1, 2004, Pages 187-199

  Schwarz, James K ^a   Giese, William ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; GEMCITABINE; PILOCARPINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DYSPHAGIA; HEAD AND NECK CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; HYPOTENSION; INTENSITY MODULATED RADIATION THERAPY; LARYNGECTOMY; LARYNX CARCINOMA; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CARCINOMA; NAUSEA; NEUROMUSCULAR DISEASE; NEUROMUSCULAR FUNCTION; ORGAN PRESERVATION; OROPHARYNX CARCINOMA; QUALITY OF LIFE; RADIATION EXPOSURE; RASH; REVIEW; SALIVARY GLAND; SIDE EFFECT; SPEECH DISORDER; SQUAMOUS CELL CARCINOMA; VOICE; XEROSTOMIA;

DEGLUTITION; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS, SQUAMOUS CELL; RADIOTHERAPY; SALIVARY GLANDS; SALIVATION; VOICE QUALITY; XEROSTOMIA;

EID: 1542327281     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(03)00120-0     Document Type: Review

References (56)

1. De Boer M.F., McCormick L.K., Pruyn J.F., Ryckman R.M., van den Borne B.W. Physical and psychosocial correlates of head and neck cancer: a review of the literature. Otolaryngol Head Neck Surg. 120:1999;427-436.
2. Jalukar V., Funk G.F., Christensen A.J., Karnell L.H., Moran P.J. Health states following head and neck cancer treatment: patient, health-care professional, and public perspectives. Head Neck. 20:1998;600-608.
3. List M.A., Stracks J., Colangelo L., Butler P., Ganzenko N., Lundy D., et al. How do head and neck cancer patients prioritize treatment outcomes before initiating treatment? J Clin Oncol. 18:2000;877-884.
4. Sharp H.M., List M., MacCracken E., Stenson K., Stocking C., Siegler M. Patients' priorities among treatment effects in head and neck cancer: evaluation of a new assessment tool. Head Neck. 21:1999;538-546.
5. Jacobs C., Goffinet D.R., Goffinet L., Kohler M., Fee W.E. Chemotherapy as a substitute for surgery in the treatment advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer. 60:1987;1178-1183.
6. Karp D.D., Vaughan C.W., Carter R., Willett B., Heeren T., Calarese P., et al. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report. Am J Clin Oncol. 14:1991;273-279.
7. Urba S.G., Forastiere A.A., Wolf G.T., Esclamado R.M., McLaughlin P.W., Thornton A.F. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. J Clin Oncol. 12:1994;946-953.
8. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 324:1991;1685-1690.
9. Lefebvre J.L., Chevalier D., Luboinski B., Kirkpatrick A., Collette L., Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 88:1996;890-899.
10. Richard J.M., Sancho-Garnier H., Pessey J.J., Luboinski B., Lefebvre J.L., Dehesdin D., et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol. 34:1998;224-228.
11. Pignon J.P., Bourhis J., Domenge C., Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 355:2000;949-955.
12. Hillman R.E., Walsh M.J., Wolf G.T., Fisher S.G., Hong W.K. Functional outcomes following treatment for advanced laryngeal cancer Part I - voice preservation in advanced laryngeal cancer. Part II - laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol Suppl. 172:1998;1-27.
13. Terrell J.E., Fisher S.G., Wolf G.T. Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg. 124:1998;964-971.
14. Smith J.C., Meyers E.N. Progress in laryngeal surgery. Head Neck. 24:2002;955-964.
15. Forastiere A.A., Goepfert H., Maor M., Rajak T.F., Weber R., Morrison W., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. New Engl J Med. 349:(22):2003(Nov 27);2091. [abstract].
16. de Graeff A., de Leeuw R.J., Ros W.J., Hordijk G.J., Battermann J.J., Blijham G.H., et al. A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy. Head Neck. 21:1999;291-296.
17. DeSanto L.W., Olsen K.D., Perry W.C., Rohe D.E., Keith R.L. Quality of life after surgical treatment of cancer of the larynx. Ann Otol Rhinol Laryngol. 104:1995;763-769.
18. Blom E.D. Current status of voice restoration following total laryngectomy. Oncology (Huntingt). 14:2000;915-922. [discussion: 927-8, 931].
19. Finizia C., Dotevall H., Lundstrom E., Lindstrom J. Acoustic and perceptual evaluation of voice and speech quality: a study of patients with laryngeal cancer treated with laryngectomy vs irradiation. Arch Otolaryngol Head Neck Surg. 125:1999;157-163.
20. Finizia C., Lindstrom J., Dotevall H. Intelligibility and perceptual ratings after treatment for laryngeal cancer: laryngectomy versus radiotherapy. Laryngoscope. 108:1998;138-143.
21. Woodson G.E., Rosen C.A., Murry T., Madasu R., Wong F., Hengesteg A., et al. Assessing vocal function after chemoradiation for advanced laryngeal carcinoma. Arch Otolaryngol Head Neck Surg. 122:1996;858-864.
22. Rosen A., Rhee T.H., Kaufman R. Prediction of aspiration in patients with newly diagnosed untreated advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 127:2001;975-979.
23. Stenson K.M., MacCracken E., List M., Haraf D.J., Brockstein B., Weichselbaum R., et al. Swallowing function in patients with head and neck cancer prior to treatment. Arch Otolaryngol Head Neck Surg. 126:2000;371-377.
24. Pauloski B.R., Rademaker A.W., Logemann J.A., Stein D., Beery Q., Newman L., et al. Pretreatment swallowing function in patients with head and neck cancer. Head Neck. 22:2000;474-482.
25. Harrison L.B., Zelefsky M.J., Armstrong J.G., Carper E., Gaynor J.J., Sessions R.B. Performance status after treatment for squamous cell cancer of the base of tongue - a comparison of primary radiation therapy versus primary surgery. Int J Radiat Oncol Biol Phys. 30:1994;953-957.
26. Friedlander P., Caruana S., Singh B., Shaha A., Kraus D., Harrison L., et al. Functional status after primary surgical therapy for squamous cell carcinoma of the base of the tongue. Head Neck. 24:2002;111-114.
27. Kronenberger M.B., Meyers A.D. Dysphagia following head and neck cancer surgery. Dysphagia. 9:1994;236-244.
28. Anthony J.P., Singer M.I., Deschler D.G., Dougherty E.T., Reed C.G., Kaplan M.J. Long-term functional results after pharyngoesophageal reconstruction with the radial forearm free flap. Am J Surg. 168:1994;441-445.
29. McConnel F.M., O'Connor A. Dysphagia secondary to head and neck cancer surgery. Acta Otorhinolaryngol Belg. 48:1994;165-170.
30. Stachler R.J., Hamlet S.L., Mathog R.H., Jones L., Heilbrun L.K., Manov L.J., et al. Swallowing of bolus types by postsurgical head and neck cancer patients. Head Neck. 16:1994;413-419.
31. Teichgraeber J., Bowman J., Goepfert H. New test series for the functional evaluation of oral cavity cancer. Head Neck Surg. 8:1985;9-20.
32. Hamlet S., Faull J., Klein B., Aref A., Fontanesi J., Stachler R., et al. Mastication and swallowing in patients with postirradiation xerostomia. Int J Radiat Oncol Biol Phys. 37:1997;789-796.
33. Logemann J.A., Smith C.H., Pauloski B.R., Rademaker A.W., Lazarus C.L., Colangelo L.A., et al. Effects of xerostomia on perception and performance of swallow function. Head Neck. 23:2001;317-321.
34. Kendall K.A., McKenzie S.W., Leonard R.J., Jones C.U. Timing of swallowing events after single-modality treatment of head and neck carcinomas with radiotherapy. Ann Otol Rhinol Laryngol. 109:2000;767-775.
35. Lazarus C.L. Management of swallowing disorders in head and neck cancer patients: optimal patterns of care. Semin Speech Lang. 21:2000;293-309.
36. Lazarus C.L., Logemann J.A., Pauloski B.R., Colangelo L.A., Kahrilas P.J., Mittal B.B., et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope. 106:1996;1157-1166.
37. Pauloski B.R., Rademaker A.W., Logemann J.A., Lazarus C.L., Newman L., Hamner A., et al. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck. 24:2002;555-565.
38. Smith R.V., Kotz T., Beitler J.J., Wadler S. Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: initial results. Arch Otolaryngol Head Neck Surg. 126:2000;384-389.
39. Kotz T., Abraham S., Beitler J.J., Wadler S., Smith R.V. Pharyngeal transport dysfunction consequent to an organ-sparing protocol. Arch Otolaryngol Head Neck Surg. 125:1999;410-413.
40. Eisbruch A., Lyden T., Bradford C.R., Dawson L.A., Haxer M.J., Miller A.E., et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 53:2002;23-28.
41. Newman L.A., Robbins K.T., Logemann J.A., Rademaker A.W., Lazarus C.L., Hamner A., et al. Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head Neck. 24:2002;68-77.
42. List M.A., Siston A., Haraf D., Schumm P., Kies M., Stenson K., et al. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol. 17:1999;1020-1028.
43. Patt H., Tyree E.B., Straube R.I., Too O.G. Cysteine protection against x-irradiation. Science. 110:1949;213-214.
44. Dorr R.T. Radioprotectants: pharmacology and clinical applications of amifostine. Semin Radiat Oncol. 8:1998;10-13.
45. Peters G.J., van der Vijgh W.J. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): preclinical aspects. Eur J Cancer. 31A:1995;S1-S7.
46. Koukourakis M.I. Amifostine in clinical oncology: current use and future applications. Anticancer Drugs. 13:2002;181-209.
47. Brizel D.M., Wasserman T.H., Henke M., Strnad V., Rudat V., Monnier A., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 18:2000;3339-3345.
48. Cheng J.C., Chao K.S., Low D. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma. Int J Cancer. 96:2001;126-131.
49. Chao K.S., Deasy J.O., Markman J., Haynie J., Perez C.A., Purdy J.A., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys. 49:2001;907-916.
50. Fisher J., Scott C., Scarantino C.W., Leveque F.G., White R.L., Rotman M., et al. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer - RTOG 97-09. International J Radiation Oncology, Biology, Physics. 56:(3):2003(Jul 1);832-836.
51. August M., Wang J., Plante D., Wang C.C. Complications associated with therapeutic neck radiation. J Oral Maxillofac Surg. 54:1996;1409-1415. [discussion: 1415-6].
52. Chepeha D.B., Taylor R.J., Chepeha J.C., Teknos T.N., Bradford C.R., Sharma P.K., et al. Functional assessment using Constant's Shoulder Scale after modified radical and selective neck dissection. Head Neck. 24:2002;432-436.
53. Kuntz A.L., Weymuller E.A. Jr. Impact of neck dissection on quality of life. Laryngoscope. 109:1999;1334-1338.
54. Taylor R.J., Chepeha J.C., Teknos T.N., Bradford C.R., Sharma P.K., Terrell J.E., et al. Development and validation of the neck dissection impairment index: a quality of life measure. Arch Otolaryngol Head Neck Surg. 128:2002;44-49.
55. Terrell J.E., Welsh D.E., Bradford C.R., Chepeha D.B., Esclamado R.M., Hogikyan N.D., et al. Pain, quality of life, and spinal accessory nerve status after neck dissection. Laryngoscope. 110:2000;620-626.
56. Adelstein D.J., Saxton J.P., Lavertu P., Rybicki L.A., Esclamado R.M., Wood B.G., et al. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol. 20:2002;1405-1410.